Few biomarkers progress from discovery to become validated tools or diagnostics. To bridge this gap, three European biomedical research infrastructures — EATRIS-ERIC (focused on translational medicine), BBMRI-ERIC (focused on biobanking) and ELIXIR (focused on data sharing) — are paving the way to developing and sharing best practices for biomarker validation.

中文翻译：

---

通过良好的生物标志物实践弥合翻译创新鸿沟

很少有生物标记物从发现发展为经过验证的工具或诊断程序。为了弥合这一差距，三个欧洲生物医学研究基础设施-专注于转化医学的EATRIS-ERIC，专注于生物银行的BBMRI-ERIC和专注于数据共享的ELIXIR-正在为开发和共享生物标志物的最佳实践铺平道路验证。